These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3986080)

  • 1. Effects of ranitidine on the disposition of metoprolol.
    Kelly JG; Salem SA; Kinney CD; Shanks RG; McDevitt DG
    Br J Clin Pharmacol; 1985 Feb; 19(2):219-24. PubMed ID: 3986080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The racemic metoprolol H2-antagonist interaction.
    Toon S; Davidson EM; Garstang FM; Batra H; Bowes RJ; Rowland M
    Clin Pharmacol Ther; 1988 Mar; 43(3):283-9. PubMed ID: 3345620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of ranitidine and cimetidine on the pharmacokinetics and pharmacodynamics of metoprolol.
    Chellingsworth MC; Laugher S; Akhlaghi S; Jack DB; Kendall MJ
    Aliment Pharmacol Ther; 1988 Dec; 2(6):521-7. PubMed ID: 2979275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic and pharmacodynamic properties of metoprolol in patients with impaired renal function.
    Jordö L; Attman PO; Aurell M; Johansson L; Johnsson G; Regårdh CG
    Clin Pharmacokinet; 1980; 5(2):169-80. PubMed ID: 6102500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metoprolol kinetics and dose response in hypertensive patients.
    Myers MG; Thiessen JJ
    Clin Pharmacol Ther; 1980 Jun; 27(6):756-62. PubMed ID: 7379442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of ranitidine following oral administration with ascending doses and with multiple-fixed doses.
    Garg DC; Eshelman FN; Weidler DJ
    J Clin Pharmacol; 1985 Sep; 25(6):437-43. PubMed ID: 4056078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of ranitidine on the absorption of aspirin.
    Corrocher R; Bambara LM; Caramaschi P; Testi R; Girelli M; Pellegatti M; Lomeo A
    Digestion; 1987; 37(3):178-83. PubMed ID: 3653532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of single-dose pharmacokinetic and pharmacodynamic properties of two metoprolol Oros systems with different initial zero-order release rates.
    Warrington SJ; Barclay SP; John VA; Shotton PA; Good W
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):225S-230S. PubMed ID: 4005127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of ranitidine on the disposition of lignocaine.
    Robson RA; Wing LM; Miners JO; Lillywhite KJ; Birkett DJ
    Br J Clin Pharmacol; 1985 Aug; 20(2):170-3. PubMed ID: 4041336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ranitidine and cimetidine; drug interactions with single dose and steady-state nifedipine administration.
    Smith SR; Kendall MJ; Lobo J; Beerahee A; Jack DB; Wilkins MR
    Br J Clin Pharmacol; 1987 Mar; 23(3):311-5. PubMed ID: 3567045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of metoprolol in patients with hepatic cirrhosis.
    Regårdh CG; Jordö L; Ervik M; Lundborg P; Olsson R; Rönn O
    Clin Pharmacokinet; 1981; 6(5):375-88. PubMed ID: 7333059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of pretreatment with cimetidine on the bioavailability and disposition of atenolol and metoprolol.
    Houtzagers JJ; Streurman O; Regårdh CG
    Br J Clin Pharmacol; 1982 Jul; 14(1):67-72. PubMed ID: 6125199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multiple dose pharmacokinetic and pharmacodynamic evaluation of conventional and 19/285 Oros formulations of metoprolol in healthy volunteers.
    Grainger SL; John VA; Shotton PA; Smith SE
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):239S-244S. PubMed ID: 4005129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender-related effects on metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers.
    Luzier AB; Killian A; Wilton JH; Wilson MF; Forrest A; Kazierad DJ
    Clin Pharmacol Ther; 1999 Dec; 66(6):594-601. PubMed ID: 10613615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability and disposition of metoprolol and hydrochlorothiazide combined in one tablet and of separate doses of hydrochlorothiazide.
    Jordö L; Johnsson G; Lundborg P; Persson BA; Regärdh CG; Rönn O
    Br J Clin Pharmacol; 1979 Jun; 7(6):563-7. PubMed ID: 465277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of efficacy of cimetidine and ranitidine as inhibitors of tolbutamide metabolism.
    Adebayo GI; Coker HA
    Eur J Clin Pharmacol; 1988; 34(6):653-6. PubMed ID: 3169118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of ranitidine in patients with renal failure.
    Garg DC; Baltodano N; Jallad NS; Perez G; Oster JR; Eshelman FN; Weidler DJ
    J Clin Pharmacol; 1986 Apr; 26(4):286-91. PubMed ID: 3700684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose and concentration dependent effect of ranitidine on procainamide disposition and renal clearance in man.
    Somogyi A; Bochner F
    Br J Clin Pharmacol; 1984 Aug; 18(2):175-81. PubMed ID: 6091709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of verapamil in combination with atenolol, metoprolol and propranolol.
    Warrington SJ; Holt D; Johnston A; Fitzsimons TJ
    Br J Clin Pharmacol; 1984; 17 Suppl 1(Suppl 1):37S-44S. PubMed ID: 6146339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions and non-interactions with ranitidine.
    Kirch W; Hoensch H; Janisch HD
    Clin Pharmacokinet; 1984; 9(6):493-510. PubMed ID: 6096071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.